Paper1167549
The amino acid sequence of a hypothalamic peptide, neurotensin.
Carraway R and 1 other. J Biol Chem, 1975. Cited by 359 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The amino acid sequence of a hypothalamic peptide, neurotensin. Papers, record 1167549. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1167549
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypothalamus | Major topic |
| Kinins | Major topic |
| Amino Acid Sequence | |
| Amino Acids | |
| Animals | |
| Cattle | |
| Chymotrypsin | |
| Electrophoresis | |
| Molecular Weight | |
| Papain | |
| Trypsin |
Source PubMed
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 359 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,953,039 | Targeting pain where it CouNts: the role of neurotensin signaling in pain and analgesia. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42953039 | PubMed |
| 42,943,320 | Neurotensin-Based Radioligands for NTS1R-Targeted Cancer Theranostics: Background, Current Status and Future Trends. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943320 | PubMed |
| 42,117,825 | Neurotensin Receptor 1 Regulates HER4 Tyrosine Phosphorylation in Lung Cancer Cells. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42117825 | PubMed |
| 42,109,681 | Advances in neurotensin receptor 1-targeted molecular probes for tumor molecular imaging and therapy. | Front Oncol | 2026 | https://conductscience.org/library/papers/42109681 | PubMed |
| 41,988,205 | Immunomodulatory functions of glutaminyl cyclases QPCTL and QPCT. | Front Immunol | 2026 | https://conductscience.org/library/papers/41988205 | PubMed |
| 41,415,714 | Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41415714 | PubMed |
| 40,152,901 | A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice. | Elife | 2025 | https://conductscience.org/library/papers/40152901 | PubMed |
| 39,811,130 | Re-evaluation of Cyclic Peptide Binding to Neurotensin Receptor 1 by Shifting the Peptide Register during Synthesis. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/39811130 | PubMed |
| 37,534,788 | Neurotensin and Neurotensin Receptors in Stress-related Disorders: Pathophysiology & Novel Drug Targets. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/37534788 | PubMed |
| 37,242,459 | Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242459 | PubMed |
| 37,047,432 | Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047432 | PubMed |
| 36,680,775 | Ligands selectively tune the local and global motions of neurotensin receptor 1 (NTS1). | Cell Rep | 2023 | https://conductscience.org/library/papers/36680775 | PubMed |
| 36,230,845 | Development of a Neurotensin-Derived 68Ga-Labeled PET Ligand with High In Vivo Stability for Imaging of NTS1 Receptor-Expressing Tumors. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230845 | PubMed |
| 36,009,532 | Immunomodulatory Role of Neuropeptides in the Cornea. | Biomedicines | 2022 | https://conductscience.org/library/papers/36009532 | PubMed |
| 35,562,956 | Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35562956 | PubMed |
| 35,011,444 | The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors. | Molecules | 2021 | https://conductscience.org/library/papers/35011444 | PubMed |
| 34,225,977 | Chemoarchitecture of the bed nucleus of the stria terminalis: Neurophenotypic diversity and function. | Handb Clin Neurol | 2021 | https://conductscience.org/library/papers/34225977 | PubMed |
| 31,938,457 | Fluorescence Labeling of Neurotensin(8-13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity. | ACS Med Chem Lett | 2020 | https://conductscience.org/library/papers/31938457 | PubMed |
| 31,223,455 | Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS1 Receptor Affinity. | ACS Med Chem Lett | 2019 | https://conductscience.org/library/papers/31223455 | PubMed |
| 31,209,646 | Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations. | J Mol Model | 2019 | https://conductscience.org/library/papers/31209646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1167549
GET https://conductscience.org/api/papers/v1/1167549/cited_by?page=2